| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
452,469 |
364,073 |
$39.90M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
15,024 |
12,179 |
$3.92M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
24,890 |
23,279 |
$3.19M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
23,870 |
22,176 |
$2.87M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
24,452 |
21,908 |
$2.60M |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
26,795 |
25,448 |
$1.78M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
8,058 |
7,669 |
$1.77M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
3,695 |
3,523 |
$1.13M |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
5,739 |
3,103 |
$1.10M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
9,146 |
8,749 |
$1.08M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
12,241 |
8,366 |
$1.05M |
| 70450 |
Computed tomography, head or brain; without contrast material |
6,666 |
6,140 |
$889K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
4,361 |
3,244 |
$887K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
4,091 |
3,978 |
$830K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
2,284 |
2,158 |
$828K |
| 80053 |
Comprehensive metabolic panel |
101,520 |
86,029 |
$722K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
5,771 |
3,047 |
$715K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
4,844 |
4,129 |
$682K |
| 17110 |
|
3,545 |
3,341 |
$589K |
| G0378 |
Hospital observation service, per hour |
12,035 |
5,520 |
$581K |
| 20610 |
|
4,721 |
4,361 |
$542K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,595 |
2,483 |
$492K |
| 59025 |
Fetal non-stress test |
3,445 |
1,630 |
$483K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
1,812 |
1,751 |
$479K |
| 64615 |
|
2,443 |
2,307 |
$461K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
6,096 |
3,406 |
$450K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
1,966 |
1,910 |
$393K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
3,981 |
3,755 |
$375K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
16,026 |
15,787 |
$372K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,786 |
1,715 |
$339K |
| 36415 |
Collection of venous blood by venipuncture |
169,173 |
135,587 |
$333K |
| 96415 |
|
1,589 |
1,122 |
$302K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
1,809 |
1,769 |
$296K |
| 76830 |
Ultrasound, transvaginal |
3,305 |
3,178 |
$288K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
591 |
586 |
$282K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
11,833 |
5,003 |
$279K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
961 |
919 |
$277K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
99,918 |
80,931 |
$268K |
| 11102 |
|
1,106 |
1,068 |
$256K |
| 71046 |
Radiologic examination, chest; 2 views |
14,426 |
13,824 |
$252K |
| 84443 |
Thyroid stimulating hormone (TSH) |
32,636 |
31,370 |
$247K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
2,185 |
2,151 |
$228K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13,999 |
13,522 |
$226K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
1,802 |
1,717 |
$225K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
3,955 |
3,786 |
$223K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
731 |
710 |
$223K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
1,188 |
1,152 |
$215K |
| 12001 |
|
1,048 |
1,020 |
$208K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
8,218 |
4,674 |
$184K |
| 73630 |
|
9,320 |
8,689 |
$179K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
9,452 |
9,039 |
$176K |
| 73221 |
|
933 |
905 |
$173K |
| 93017 |
|
2,102 |
2,045 |
$173K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
2,196 |
2,162 |
$173K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
11,236 |
10,813 |
$173K |
| 76801 |
|
2,683 |
2,413 |
$172K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
2,035 |
1,964 |
$168K |
| 93971 |
|
1,938 |
1,867 |
$166K |
| 11750 |
|
479 |
437 |
$166K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
1,510 |
1,465 |
$165K |
| 52000 |
|
369 |
355 |
$161K |
| 10060 |
|
942 |
894 |
$161K |
| J9271 |
Injection, pembrolizumab, 1 mg |
32 |
24 |
$158K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,261 |
3,073 |
$158K |
| 80061 |
Lipid panel |
22,221 |
21,769 |
$151K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
20,663 |
14,882 |
$151K |
| 73562 |
|
7,207 |
6,877 |
$140K |
| 73110 |
|
6,258 |
5,310 |
$140K |
| 73130 |
|
6,564 |
5,866 |
$139K |
| 73610 |
|
7,117 |
6,458 |
$138K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
17,871 |
15,736 |
$138K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
30,245 |
25,917 |
$136K |
| 73030 |
|
6,628 |
6,126 |
$133K |
| 72141 |
|
766 |
755 |
$125K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
21,138 |
13,977 |
$123K |
| 84484 |
|
17,044 |
12,143 |
$121K |
| 29125 |
|
720 |
686 |
$118K |
| 90461 |
|
8,232 |
8,116 |
$114K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
23,664 |
23,083 |
$111K |
| 76770 |
|
1,173 |
1,144 |
$111K |
| 87507 |
|
1,709 |
1,654 |
$110K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
1,689 |
1,616 |
$109K |
| 17000 |
|
1,205 |
1,161 |
$107K |
| 70496 |
|
647 |
619 |
$106K |
| 84439 |
|
12,816 |
12,443 |
$106K |
| 71250 |
|
1,369 |
1,325 |
$105K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,946 |
1,848 |
$101K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
11,230 |
10,788 |
$99K |
| 90715 |
|
6,376 |
6,215 |
$92K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
17,665 |
13,644 |
$91K |
| 71045 |
Radiologic examination, chest; single view |
14,417 |
12,993 |
$91K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
16,302 |
13,051 |
$90K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
13,691 |
13,439 |
$90K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,754 |
1,570 |
$89K |
| 64450 |
|
432 |
363 |
$85K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
4,706 |
2,132 |
$85K |
| 97597 |
|
2,804 |
1,748 |
$83K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,585 |
2,361 |
$83K |
| 72100 |
|
3,530 |
3,432 |
$78K |
| 96900 |
|
2,751 |
577 |
$78K |
| 95886 |
|
731 |
706 |
$76K |
| 69210 |
|
1,703 |
1,654 |
$76K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
22,353 |
20,898 |
$75K |
| 85027 |
|
22,047 |
20,140 |
$75K |
| 96367 |
|
2,311 |
1,777 |
$74K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,993 |
1,780 |
$73K |
| 11100 |
|
265 |
250 |
$71K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
1,246 |
1,139 |
$71K |
| 73140 |
|
3,867 |
3,384 |
$71K |
| 96376 |
|
8,794 |
5,398 |
$70K |
| 87040 |
|
6,850 |
3,867 |
$69K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
217 |
209 |
$69K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,954 |
862 |
$69K |
| 10061 |
|
318 |
304 |
$67K |
| 93975 |
|
997 |
950 |
$65K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
37 |
37 |
$64K |
| 83605 |
|
7,503 |
6,235 |
$61K |
| 82728 |
|
9,627 |
9,326 |
$60K |
| 90651 |
|
3,470 |
3,429 |
$59K |
| 97162 |
|
1,823 |
1,719 |
$58K |
| 11055 |
|
490 |
464 |
$57K |
| 73080 |
|
2,857 |
2,461 |
$57K |
| 73560 |
|
3,429 |
3,190 |
$55K |
| 11721 |
|
4,261 |
4,083 |
$55K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
1,258 |
809 |
$55K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
3,998 |
3,854 |
$54K |
| 90686 |
|
12,297 |
12,100 |
$54K |
| 11900 |
|
343 |
334 |
$54K |
| 72040 |
|
2,351 |
2,297 |
$51K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
3,848 |
3,769 |
$51K |
| 74018 |
|
3,006 |
2,852 |
$50K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
4,102 |
3,146 |
$50K |
| 73502 |
|
2,827 |
2,653 |
$48K |
| 76870 |
|
454 |
441 |
$46K |
| 83690 |
|
18,303 |
16,421 |
$46K |
| 95811 |
|
100 |
100 |
$45K |
| 11056 |
|
491 |
464 |
$45K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
2,344 |
1,915 |
$45K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
3,086 |
2,801 |
$44K |
| 98928 |
|
1,760 |
1,418 |
$43K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
35,665 |
24,025 |
$41K |
| 83880 |
|
3,972 |
3,660 |
$40K |
| 97161 |
|
1,109 |
1,067 |
$39K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,899 |
932 |
$39K |
| 76536 |
|
411 |
408 |
$37K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,041 |
984 |
$36K |
| 11104 |
|
119 |
116 |
$36K |
| 90677 |
|
1,561 |
1,521 |
$35K |
| 70498 |
|
673 |
643 |
$35K |
| 82607 |
|
4,986 |
4,862 |
$35K |
| 98927 |
|
1,820 |
1,664 |
$35K |
| 83735 |
|
18,791 |
15,341 |
$35K |
| 86140 |
|
11,115 |
10,330 |
$33K |
| 95115 |
|
1,760 |
647 |
$33K |
| 87077 |
|
10,987 |
9,885 |
$32K |
| 12011 |
|
161 |
158 |
$32K |
| 97803 |
|
759 |
627 |
$32K |
| 90670 |
|
4,020 |
3,954 |
$31K |
| 84702 |
|
5,125 |
3,978 |
$31K |
| 84145 |
|
2,778 |
2,289 |
$31K |
| 72110 |
|
1,366 |
1,339 |
$31K |
| 83655 |
|
2,073 |
2,052 |
$31K |
| 20550 |
|
254 |
240 |
$31K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
1,027 |
836 |
$30K |
| 81001 |
|
19,218 |
17,614 |
$30K |
| 83550 |
|
7,817 |
7,597 |
$29K |
| 86592 |
|
5,733 |
5,598 |
$29K |
| 83970 |
|
1,620 |
1,523 |
$29K |
| 87070 |
|
5,883 |
5,431 |
$28K |
| 73090 |
|
1,470 |
1,222 |
$28K |
| 85379 |
|
4,034 |
3,861 |
$28K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
448 |
433 |
$28K |
| 81025 |
|
23,886 |
22,164 |
$28K |
| 73590 |
|
1,508 |
1,368 |
$27K |
| 86480 |
|
1,712 |
1,657 |
$26K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
5,906 |
5,775 |
$26K |
| 83540 |
|
7,955 |
7,703 |
$26K |
| 70486 |
|
367 |
360 |
$26K |
| 97602 |
|
290 |
121 |
$25K |
| 70491 |
|
164 |
160 |
$25K |
| 94060 |
|
578 |
561 |
$25K |
| 87181 |
|
10,069 |
9,178 |
$25K |
| 98926 |
|
1,552 |
1,438 |
$25K |
| 82075 |
|
5,849 |
4,576 |
$25K |
| 95806 |
|
66 |
63 |
$25K |
| 82570 |
|
6,698 |
6,157 |
$24K |
| 0071A |
|
635 |
622 |
$24K |
| J2704 |
Injection, propofol, 10 mg |
16,369 |
14,165 |
$24K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
27 |
27 |
$24K |
| 85610 |
|
13,363 |
10,740 |
$24K |
| 80305 |
|
8,850 |
8,069 |
$24K |
| 12002 |
|
150 |
144 |
$24K |
| 82962 |
|
24,717 |
12,658 |
$23K |
| 86803 |
|
4,085 |
3,986 |
$23K |
| 99152 |
|
2,916 |
2,763 |
$22K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
12,251 |
7,289 |
$22K |
| 87088 |
|
8,332 |
7,979 |
$22K |
| 87081 |
|
5,129 |
5,035 |
$22K |
| 87486 |
|
1,041 |
984 |
$22K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
2,142 |
2,103 |
$22K |
| 83516 |
|
2,318 |
1,496 |
$21K |
| 97802 |
|
340 |
339 |
$21K |
| 82746 |
|
3,458 |
3,376 |
$21K |
| 87511 |
|
1,569 |
1,532 |
$20K |
| 86850 |
|
5,743 |
5,133 |
$19K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
15,898 |
11,778 |
$19K |
| 87340 |
|
4,853 |
4,714 |
$19K |
| 86900 |
|
6,225 |
5,544 |
$19K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,898 |
1,865 |
$19K |
| 72050 |
|
870 |
852 |
$19K |
| 11901 |
|
165 |
164 |
$18K |
| 0001A |
|
470 |
451 |
$18K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
41 |
39 |
$18K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
12,781 |
11,443 |
$17K |
| 82784 |
|
2,068 |
1,866 |
$17K |
| 73564 |
|
592 |
569 |
$17K |
| 81002 |
|
30,523 |
27,743 |
$17K |
| J7050 |
Infusion, normal saline solution, 250 cc |
22,626 |
10,769 |
$16K |
| 87581 |
|
1,041 |
984 |
$16K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
3,403 |
3,235 |
$16K |
| 84403 |
|
1,440 |
1,371 |
$16K |
| 82043 |
|
4,565 |
4,448 |
$16K |
| 77336 |
|
294 |
118 |
$15K |
| 87481 |
|
2,513 |
1,778 |
$15K |
| 80074 |
|
1,070 |
1,049 |
$15K |
| 51798 |
|
3,267 |
3,088 |
$14K |
| 93296 |
|
1,503 |
1,478 |
$14K |
| 87205 |
|
7,783 |
7,262 |
$14K |
| 20553 |
|
131 |
121 |
$14K |
| 94726 |
|
530 |
519 |
$14K |
| 86787 |
|
2,743 |
2,505 |
$13K |
| 73100 |
|
468 |
389 |
$13K |
| 90750 |
|
177 |
171 |
$13K |
| 76937 |
|
666 |
612 |
$13K |
| 82105 |
|
1,220 |
1,157 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13,798 |
13,108 |
$13K |
| 43235 |
|
28 |
28 |
$13K |
| 83001 |
|
1,140 |
1,116 |
$12K |
| 84153 |
|
1,542 |
1,501 |
$12K |
| 71101 |
|
770 |
750 |
$12K |
| 0002A |
|
330 |
327 |
$12K |
| 99153 |
Mod sedat endo service >5yrs |
1,567 |
1,467 |
$12K |
| 94729 |
|
553 |
539 |
$12K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
223 |
170 |
$12K |
| 85651 |
|
5,284 |
4,988 |
$12K |
| 86255 |
|
710 |
661 |
$12K |
| 96417 |
|
1,170 |
668 |
$12K |
| 82247 |
|
2,430 |
1,681 |
$11K |
| 93970 |
|
127 |
125 |
$11K |
| 88142 |
|
744 |
730 |
$11K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
11,536 |
7,089 |
$11K |
| J0897 |
Injection, denosumab, 1 mg |
67 |
64 |
$11K |
| 82805 |
|
1,842 |
1,550 |
$11K |
| 86038 |
|
2,522 |
2,117 |
$10K |
| 73501 |
|
576 |
540 |
$10K |
| 11045 |
|
39 |
24 |
$10K |
| 73000 |
|
421 |
355 |
$10K |
| C1769 |
Guide wire |
1,546 |
1,413 |
$10K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,048 |
2,723 |
$10K |
| 82550 |
|
3,421 |
2,706 |
$10K |
| 76820 |
|
253 |
195 |
$10K |
| 69209 |
|
416 |
404 |
$10K |
| 83050 |
|
1,761 |
1,492 |
$10K |
| 86901 |
|
6,354 |
5,636 |
$10K |
| 83520 |
|
835 |
753 |
$10K |
| 58300 |
|
84 |
78 |
$10K |
| 84146 |
|
821 |
798 |
$10K |
| 0124A |
|
375 |
355 |
$9K |
| 85014 |
|
2,714 |
2,176 |
$9K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
21,356 |
20,276 |
$9K |
| 72072 |
|
476 |
464 |
$9K |
| 87522 |
Neg quan hep c or qual rna |
339 |
319 |
$9K |
| 86762 |
|
2,528 |
2,453 |
$8K |
| 73120 |
|
327 |
289 |
$8K |
| 90734 |
|
1,305 |
1,297 |
$8K |
| 82248 |
|
2,515 |
1,748 |
$8K |
| 88307 |
|
152 |
144 |
$8K |
| 64721 |
|
13 |
13 |
$8K |
| 80076 |
|
1,412 |
1,356 |
$8K |
| 86704 |
|
1,708 |
1,655 |
$8K |
| 85007 |
|
3,359 |
2,851 |
$8K |
| 88342 |
|
749 |
714 |
$8K |
| 0072A |
|
203 |
200 |
$7K |
| 72197 |
|
26 |
26 |
$7K |
| 72070 |
|
430 |
423 |
$7K |
| 82950 |
|
1,860 |
1,800 |
$7K |
| 87075 |
|
1,834 |
1,607 |
$7K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
15,879 |
13,935 |
$7K |
| 86706 |
|
1,691 |
1,652 |
$7K |
| 83002 |
|
803 |
781 |
$7K |
| 81000 |
|
8,146 |
7,100 |
$7K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
6,040 |
5,001 |
$7K |
| 86695 |
|
939 |
912 |
$7K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
67 |
66 |
$7K |
| 76942 |
|
110 |
105 |
$7K |
| 0064A |
|
228 |
223 |
$7K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
761 |
732 |
$7K |
| 36000 |
|
2,080 |
2,036 |
$7K |
| 0054A |
|
249 |
244 |
$7K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
8,220 |
7,861 |
$7K |
| 84460 |
|
2,905 |
2,833 |
$7K |
| 85652 |
|
4,596 |
4,419 |
$7K |
| 85018 |
|
4,081 |
3,363 |
$7K |
| 88304 |
|
1,278 |
1,247 |
$6K |
| 11730 |
|
44 |
42 |
$6K |
| 0004A |
|
224 |
218 |
$6K |
| 20605 |
|
44 |
39 |
$6K |
| 87428 |
|
6,050 |
5,930 |
$6K |
| 76882 |
|
68 |
63 |
$6K |
| 84550 |
|
2,774 |
2,604 |
$6K |
| 87529 |
|
247 |
182 |
$6K |
| 73660 |
|
402 |
383 |
$6K |
| 87521 |
Neg quan hep c or qual rna |
209 |
199 |
$6K |
| 98925 |
|
478 |
453 |
$6K |
| 84156 |
|
2,181 |
1,899 |
$5K |
| 86696 |
|
1,089 |
991 |
$5K |
| 90707 |
|
1,342 |
1,330 |
$5K |
| 87210 |
|
1,880 |
1,809 |
$5K |
| 84481 |
|
635 |
614 |
$5K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
501 |
475 |
$5K |
| 92557 |
|
255 |
253 |
$5K |
| 82375 |
|
1,775 |
1,508 |
$5K |
| 84703 |
|
1,687 |
1,646 |
$5K |
| 77002 |
|
59 |
54 |
$5K |
| 83615 |
|
2,371 |
2,071 |
$5K |
| 84450 |
|
2,240 |
2,183 |
$5K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
795 |
700 |
$5K |
| 86200 |
|
1,275 |
1,234 |
$5K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
123 |
121 |
$5K |
| 81003 |
|
4,503 |
4,270 |
$5K |
| 74022 |
|
231 |
222 |
$5K |
| 51702 |
|
511 |
440 |
$5K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
5,202 |
4,435 |
$5K |
| 20600 |
|
40 |
40 |
$5K |
| 86694 |
|
317 |
307 |
$5K |
| 29105 |
|
43 |
43 |
$5K |
| 83883 |
|
476 |
435 |
$5K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
5,024 |
4,358 |
$5K |
| 87653 |
|
291 |
286 |
$5K |
| 92652 |
|
78 |
72 |
$4K |
| 80069 |
|
976 |
810 |
$4K |
| 93308 |
|
26 |
26 |
$4K |
| 84402 |
|
416 |
398 |
$4K |
| 93299 |
|
333 |
327 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
15,287 |
12,519 |
$4K |
| 82947 |
|
1,211 |
1,187 |
$4K |
| 90732 |
|
387 |
373 |
$4K |
| 85732 |
|
2,460 |
2,097 |
$4K |
| 72156 |
|
13 |
13 |
$4K |
| 90648 |
|
2,362 |
2,321 |
$4K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
970 |
886 |
$4K |
| 17004 |
|
163 |
155 |
$4K |
| 64405 |
|
323 |
268 |
$4K |
| 82565 |
|
1,612 |
1,541 |
$4K |
| 94761 |
|
1,879 |
1,243 |
$4K |
| 96368 |
|
524 |
336 |
$4K |
| J3490 |
Unclassified drugs |
4,610 |
3,374 |
$4K |
| 92567 |
|
432 |
430 |
$4K |
| 73522 |
|
189 |
187 |
$4K |
| 72202 |
|
246 |
240 |
$4K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,463 |
2,499 |
$4K |
| 84100 |
|
2,246 |
1,791 |
$4K |
| J2060 |
Injection, lorazepam, 2 mg |
3,603 |
2,655 |
$4K |
| 80175 |
|
236 |
228 |
$4K |
| J1756 |
Injection, iron sucrose, 1 mg |
752 |
370 |
$4K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
15 |
13 |
$4K |
| 95819 |
|
25 |
25 |
$4K |
| 91322 |
|
501 |
487 |
$4K |
| 71271 |
|
39 |
38 |
$3K |
| 90480 |
|
668 |
609 |
$3K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
1,742 |
957 |
$3K |
| 78264 |
|
14 |
14 |
$3K |
| 97166 |
|
94 |
85 |
$3K |
| 31575 |
|
45 |
45 |
$3K |
| 11720 |
|
77 |
75 |
$3K |
| 95909 |
|
83 |
78 |
$3K |
| 29130 |
|
12 |
12 |
$3K |
| 0052A |
|
86 |
86 |
$3K |
| C1776 |
Joint device (implantable) |
26 |
26 |
$3K |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
1,470 |
1,412 |
$3K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
2,022 |
1,730 |
$3K |
| 98929 |
|
128 |
116 |
$3K |
| 94799 |
|
644 |
522 |
$3K |
| 73620 |
|
147 |
142 |
$3K |
| 92610 |
|
103 |
92 |
$3K |
| 74183 |
|
14 |
14 |
$3K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
3,518 |
1,540 |
$3K |
| 94664 |
|
330 |
322 |
$3K |
| 90620 |
|
1,227 |
1,208 |
$3K |
| 80143 |
|
765 |
715 |
$3K |
| 86431 |
|
853 |
838 |
$3K |
| 82274 |
|
373 |
367 |
$3K |
| 84165 |
|
764 |
710 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
5,711 |
4,188 |
$2K |
| J1644 |
Injection, heparin sodium, per 1000 units |
7,276 |
2,717 |
$2K |
| 86160 |
|
533 |
503 |
$2K |
| 0051A |
|
73 |
71 |
$2K |
| 82670 |
|
283 |
275 |
$2K |
| 87147 |
|
926 |
847 |
$2K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
1,199 |
1,110 |
$2K |
| 82077 |
|
2,548 |
2,291 |
$2K |
| 93798 |
|
55 |
12 |
$2K |
| 77080 |
|
38 |
38 |
$2K |
| 83013 |
|
113 |
110 |
$2K |
| 74420 |
|
13 |
12 |
$2K |
| J1815 |
Injection, insulin, per 5 units |
5,835 |
1,721 |
$2K |
| 95911 |
|
12 |
12 |
$2K |
| 72170 |
|
167 |
158 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
22,528 |
17,030 |
$2K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
213 |
203 |
$2K |
| 80177 |
|
138 |
129 |
$2K |
| 82553 |
|
214 |
139 |
$2K |
| 87808 |
|
1,349 |
1,307 |
$2K |
| 92526 |
|
52 |
30 |
$2K |
| 86376 |
|
210 |
207 |
$2K |
| 82652 |
|
223 |
218 |
$2K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
585 |
546 |
$2K |
| 84436 |
|
287 |
279 |
$2K |
| 97165 |
|
41 |
37 |
$2K |
| 74019 |
|
97 |
94 |
$2K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
1,928 |
1,594 |
$2K |
| 86430 |
|
545 |
521 |
$1K |
| J2785 |
Injection, regadenoson, 0.1 mg |
367 |
347 |
$1K |
| 80179 |
|
705 |
659 |
$1K |
| 90746 |
|
97 |
96 |
$1K |
| 92551 |
|
70 |
67 |
$1K |
| 72114 |
|
38 |
38 |
$1K |
| 86162 |
|
426 |
409 |
$1K |
| 82977 |
|
365 |
316 |
$1K |
| 76000 |
|
78 |
77 |
$1K |
| 94644 |
|
102 |
92 |
$1K |
| C1889 |
Implantable/insertable device, not otherwise classified |
27 |
26 |
$1K |
| 73700 |
|
29 |
26 |
$1K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,476 |
1,224 |
$1K |
| 0074A |
|
27 |
26 |
$1K |
| 36430 |
|
19 |
12 |
$1K |
| 83721 |
|
597 |
583 |
$1K |
| 82140 |
|
194 |
179 |
$1K |
| 86317 |
|
215 |
210 |
$1K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
377 |
345 |
$1K |
| C1758 |
Catheter, ureteral |
1,393 |
1,323 |
$1K |
| 36416 |
|
982 |
883 |
$1K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
472 |
460 |
$1K |
| 72082 |
|
40 |
40 |
$1K |
| G0008 |
Administration of influenza virus vaccine |
1,504 |
1,460 |
$1K |
| 82150 |
|
220 |
210 |
$1K |
| 72120 |
|
54 |
53 |
$1K |
| 72146 |
|
13 |
13 |
$1K |
| 84520 |
|
680 |
661 |
$1K |
| 0081A |
|
25 |
25 |
$1K |
| 84479 |
|
250 |
244 |
$1K |
| 84112 |
|
199 |
181 |
$969.29 |
| 90688 |
|
249 |
248 |
$955.43 |
| 82677 |
|
46 |
45 |
$947.71 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
16 |
16 |
$936.00 |
| 73552 |
|
57 |
55 |
$930.91 |
| 72131 |
|
13 |
13 |
$914.41 |
| 87186 |
|
334 |
297 |
$912.86 |
| 97535 |
Self-care/home management training, each 15 minutes |
67 |
52 |
$887.62 |
| 86364 |
|
402 |
392 |
$877.20 |
| 82378 |
|
154 |
130 |
$874.65 |
| 90678 |
|
125 |
117 |
$870.86 |
| 86308 |
|
242 |
234 |
$832.65 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
7,358 |
3,608 |
$831.85 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,937 |
2,548 |
$825.86 |
| 82533 |
|
77 |
71 |
$814.34 |
| 84478 |
|
518 |
504 |
$804.56 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,544 |
1,007 |
$769.91 |
| 74174 |
|
16 |
16 |
$762.26 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
247 |
228 |
$730.00 |
| 86300 |
|
73 |
63 |
$719.33 |
| 90656 |
|
131 |
131 |
$703.90 |
| 96402 |
|
73 |
64 |
$694.35 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
1,852 |
1,516 |
$680.88 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
5,824 |
4,075 |
$633.16 |
| 86708 |
|
125 |
123 |
$619.78 |
| 73060 |
|
51 |
49 |
$604.25 |
| 87641 |
|
65 |
65 |
$590.23 |
| 82040 |
|
214 |
200 |
$588.45 |
| 91321 |
|
32 |
31 |
$570.77 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,936 |
2,735 |
$552.40 |
| 0003A |
|
13 |
13 |
$527.50 |
| 87807 |
|
477 |
472 |
$526.06 |
| 84155 |
|
466 |
418 |
$525.13 |
| Q2034 |
Influenza virus vaccine, split virus, for intramuscular use (agriflu) |
387 |
377 |
$510.56 |
| 80164 |
|
42 |
38 |
$498.97 |
| 0082A |
|
12 |
12 |
$496.48 |
| 0352U |
|
1,340 |
1,296 |
$488.08 |
| 88360 |
|
13 |
12 |
$463.73 |
| 95874 |
|
274 |
226 |
$460.61 |
| 93289 |
|
51 |
48 |
$459.87 |
| 93288 |
|
63 |
60 |
$409.77 |
| 17003 |
|
249 |
243 |
$408.78 |
| 84075 |
|
162 |
153 |
$390.64 |
| 85045 |
|
182 |
168 |
$375.78 |
| J1790 |
Injection, droperidol, up to 5 mg |
735 |
576 |
$373.49 |
| 90662 |
|
477 |
458 |
$358.07 |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
28 |
26 |
$355.86 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
279 |
138 |
$354.62 |
| 86800 |
|
99 |
96 |
$350.52 |
| 88312 |
|
87 |
83 |
$342.99 |
| 80178 |
|
37 |
37 |
$321.30 |
| 86231 |
|
119 |
119 |
$318.77 |
| 86580 |
|
52 |
43 |
$318.70 |
| 86003 |
|
45 |
39 |
$315.95 |
| 81374 |
|
108 |
106 |
$311.06 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
1,377 |
1,047 |
$309.38 |
| C1892 |
Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away |
40 |
40 |
$306.95 |
| 97116 |
|
43 |
24 |
$300.16 |
| 83010 |
|
36 |
36 |
$283.87 |
| 88341 |
|
58 |
56 |
$280.27 |
| 86780 |
|
25 |
24 |
$278.03 |
| J3480 |
Injection, potassium chloride, per 2 meq |
504 |
233 |
$275.06 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,136 |
935 |
$273.69 |
| 94760 |
|
133 |
117 |
$268.05 |
| 82310 |
|
148 |
142 |
$262.45 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
6,254 |
5,561 |
$261.44 |
| 86336 |
|
46 |
45 |
$259.83 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
171 |
93 |
$236.26 |
| 85049 |
|
148 |
144 |
$235.22 |
| 90716 |
|
1,299 |
1,289 |
$233.86 |
| 82009 |
|
25 |
24 |
$232.91 |
| 95024 |
|
12 |
12 |
$222.57 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
1,016 |
789 |
$220.60 |
| 72220 |
|
13 |
13 |
$208.04 |
| 86705 |
|
40 |
38 |
$206.89 |
| 90710 |
|
1,346 |
1,322 |
$201.92 |
| 87338 |
|
24 |
24 |
$199.88 |
| 82172 |
|
36 |
35 |
$196.22 |
| A6449 |
Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard |
2,591 |
1,657 |
$193.40 |
| 99497 |
|
14 |
13 |
$192.26 |
| 90680 |
|
2,782 |
2,721 |
$177.47 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
40 |
38 |
$172.27 |
| 86735 |
|
24 |
24 |
$171.20 |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
13 |
13 |
$157.24 |
| 87184 |
|
66 |
62 |
$155.75 |
| 0296T |
|
13 |
13 |
$142.69 |
| 90698 |
|
2,281 |
2,250 |
$137.14 |
| 86778 |
|
13 |
13 |
$135.33 |
| 99495 |
|
25 |
24 |
$135.23 |
| J3372 |
Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg |
134 |
80 |
$132.58 |
| 86225 |
|
60 |
56 |
$126.46 |
| 87045 |
|
14 |
14 |
$123.81 |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
12 |
12 |
$123.65 |
| 36600 |
|
30 |
29 |
$123.20 |
| 83718 |
|
18 |
18 |
$122.80 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
166 |
150 |
$115.90 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
211 |
128 |
$114.30 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
74 |
69 |
$113.32 |
| 86765 |
|
23 |
23 |
$109.97 |
| 87563 |
|
26 |
26 |
$109.23 |
| J7070 |
Infusion, d5w, 1000 cc |
67 |
39 |
$107.46 |
| 83020 |
|
14 |
13 |
$106.40 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
44 |
39 |
$105.31 |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
12 |
12 |
$105.26 |
| 0353U |
|
1,435 |
1,396 |
$103.19 |
| 85613 |
|
17 |
12 |
$101.97 |
| 82951 |
|
12 |
12 |
$99.33 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
57 |
50 |
$98.53 |
| G0433 |
Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening |
268 |
259 |
$94.70 |
| 84132 |
|
63 |
57 |
$93.49 |
| J3360 |
Injection, diazepam, up to 5 mg |
34 |
15 |
$92.70 |
| 87427 |
|
14 |
14 |
$91.14 |
| J1630 |
Injection, haloperidol, up to 5 mg |
804 |
670 |
$88.94 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
3,432 |
2,966 |
$88.74 |
| A6454 |
Self-adherent bandage, elastic, non-knitted/non-woven, width greater than or equal to three inches and less than five inches, per yard |
1,511 |
644 |
$86.21 |
| 91305 |
|
504 |
484 |
$79.94 |
| J1956 |
Injection, levofloxacin, 250 mg |
54 |
50 |
$75.52 |
| 83525 |
|
12 |
12 |
$72.75 |
| 86258 |
|
30 |
29 |
$69.99 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,321 |
950 |
$69.39 |
| 82465 |
|
18 |
18 |
$66.69 |
| 90633 |
|
2,751 |
2,725 |
$64.70 |
| 87046 |
|
14 |
14 |
$62.11 |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
103 |
41 |
$61.42 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
214 |
159 |
$59.89 |
| J1940 |
Injection, furosemide, up to 20 mg |
106 |
80 |
$57.09 |
| 90696 |
|
1,218 |
1,196 |
$55.92 |
| 86334 |
|
12 |
12 |
$54.60 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
23 |
22 |
$54.45 |
| 82390 |
|
12 |
12 |
$52.41 |
| 93297 |
|
12 |
12 |
$51.96 |
| 96127 |
|
13 |
13 |
$49.79 |
| 82952 |
|
12 |
12 |
$49.63 |
| 90619 |
|
1,062 |
1,036 |
$48.59 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
1,650 |
1,469 |
$45.70 |
| 84295 |
|
27 |
26 |
$43.76 |
| 82374 |
|
27 |
26 |
$43.76 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
660 |
646 |
$43.25 |
| Q0177 |
Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
1,297 |
797 |
$36.08 |
| 90723 |
|
876 |
847 |
$35.80 |
| 88720 |
|
33 |
28 |
$35.06 |
| 90700 |
|
1,193 |
1,177 |
$34.58 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
157 |
135 |
$29.80 |
| 90744 |
|
1,369 |
1,353 |
$28.90 |
| 90681 |
|
368 |
363 |
$23.78 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
32 |
24 |
$22.98 |
| J3411 |
Injection, thiamine hcl, 100 mg |
55 |
37 |
$19.35 |
| 87101 |
|
13 |
13 |
$17.30 |
| J1836 |
Injection, metronidazole, 10 mg |
21 |
12 |
$13.24 |
| 99406 |
|
493 |
483 |
$12.41 |
| 81015 |
|
331 |
324 |
$12.14 |
| Q4012 |
Cast supplies, short arm cast, pediatric (0-10 years), fiberglass |
14 |
12 |
$10.68 |
| A9270 |
Non-covered item or service |
7,878 |
3,243 |
$10.62 |
| A4615 |
Cannula, nasal |
305 |
291 |
$9.11 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
215 |
197 |
$8.40 |
| G0009 |
Administration of pneumococcal vaccine |
154 |
150 |
$7.61 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
1,478 |
1,002 |
$5.12 |
| Q0144 |
Azithromycin dihydrate, oral, capsules/powder, 1 gram |
30 |
26 |
$3.18 |
| A4300 |
Implantable access catheter, (e.g., venous, arterial, epidural subarachnoid, or peritoneal, etc.) external access |
17 |
13 |
$1.33 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
17 |
16 |
$0.03 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
3,781 |
3,244 |
$0.01 |
| A6196 |
Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing |
155 |
69 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
216 |
185 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
157 |
138 |
$0.00 |
| G8990 |
Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals |
166 |
165 |
$0.00 |
| 91308 |
|
44 |
43 |
$0.00 |
| 91311 |
|
14 |
14 |
$0.00 |
| 91300 |
|
1,091 |
1,023 |
$0.00 |
| G8996 |
Swallowing functional limitation, current status at therapy episode outset and at reporting intervals |
12 |
12 |
$0.00 |
| 91312 |
|
423 |
400 |
$0.00 |
| G8997 |
Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
12 |
12 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
12 |
12 |
$0.00 |
| 85060 |
|
13 |
13 |
$0.00 |
| J3489 |
Injection, zoledronic acid, 1 mg |
17 |
17 |
$0.00 |
| 90697 |
|
24 |
24 |
$0.00 |
| 91307 |
|
923 |
844 |
$0.00 |
| 90381 |
|
39 |
33 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
470 |
395 |
$0.00 |
| G8991 |
Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
190 |
189 |
$0.00 |
| 91301 |
|
32 |
31 |
$0.00 |
| 91306 |
|
226 |
223 |
$0.00 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
12 |
12 |
$0.00 |